Inflammatory peptides derived from adipose tissue

Immunity and Ageing

Volumn 2, Issue , 2005, Pages

  Rudin, Eric ^a   Barzilai, Nir ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOTENSINOGEN; CYTOKINE; INSULIN; INTERLEUKIN 6; LEPTIN; PEPTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; AGING; ARTICLE; DISEASE MARKER; DISEASE MODEL; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NONHUMAN; NUTRIENT; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 33845225690     PISSN: 17424933     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-4933-2-1     Document Type: Article

References (23)

1. Borkan GA, Hults DE, Gerzof SG, Robbins AH, Silbert CK: Age changes in body composition revealed by computed tomography. J Gerontology 1983, 38:673-677.
2. Hughes VA, Roubenoff R, Wood M, Frontera WR, Evans WJ, Fiatarone Singh MA: Anthropometric assessment of 10-y changes in body composition in the elderly. m J Clin Nutr 2004, 80(2):475-82.
3. Das M, Gabriely I, Barzilai N: Caloric Restriction, Body fat and aging in experimental models. Obesity Research 2004, 5:13-19.
4. DeFronzo RA: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med 1997, 50:191-7.
5. Barzilai N, Gupta G: Revisiting the Role of Fat Mass in the Life Extension Induced by Caloric Restriction. J Gerontol 1999, 54A:B89-B96.
6. Stephens JM, Lee J, Pilch PF: Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 1997, 272:971-6.
7. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A: Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 1995, 270:23780-4.
8. Feinstein R, Kanety H, Papa MS, Lunenfeld B, Karasic A: Tumor necrosis factor-alfa supresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 1993, 268:26055-057.
9. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM: Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clinl Invest 1994, 94:1543-9.
10. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-8.
11. Boden, Chen X, Mozzoli M, Ryan I: Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996, 81:3419-3423.
12. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of IL-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
13. van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA, Pedersen BK: Interleukin-6 Stimulates Lipolysis and Fat Oxidation in Humans. J Clin Endocrinol Metab 2003, 88(7):3005-10.
14. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R: Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003, 301:1045-1050.
15. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001, 50:2094-2099.
16. Yukio Arita, Shinji Kihara, Noriyuki Ouchi, Masahiko Takahashi, Kazuhisa Maeda, Jun-ichiro Miyagawa, Kikuko Hotta, Iichiro Shimomura, Tadashi Nakamura, Koji Miyaoka, Hiroshi Kuriyama, Makoto Nishida, Shizuya Yamashita, Kosaku Okubo, Kenji Matsubara, Masahiro Muraguchi, Yasuichi Ohmoto, Tohru Funahashi, Yuji Matsuzawa: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7(8):941-6.
17. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y: Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999, 38:202-6.
18. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 14(291(14)):1730-7.
19. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002, 19(277(29)):25863-6.
20. Harte L, McTernan PG, McTernan CL, Smith SA, Barnett AH, Kumar S: Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes. Diabetes Obes Metab 2003, 5(5):302-10.
21. Frederich RCJ, Kahn BB, Peach MJ, Flier JS: Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992, 19:339-344.
22. Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M: Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 2001, 15(14):2727-9.
23. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherer PE, Rossetti L: Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004, 114(2):232-9.